What is the recommended treatment for acute syphilis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Acute Syphilis

Benzathine penicillin G 2.4 million units administered as a single intramuscular injection is the recommended first-line treatment for acute (early) syphilis, including primary and secondary stages. 1

First-Line Treatment

  • Benzathine penicillin G 2.4 million units intramuscularly as a single dose is the treatment of choice for primary, secondary, and early latent syphilis (less than one year duration) 1
  • Penicillin remains the treatment of choice for all stages of syphilis regardless of HIV status 1
  • Although some specialists recommend additional doses for HIV-infected patients with early syphilis, data suggest no significant benefit of multiple doses over a single dose in terms of serologic outcomes 1

Alternative Treatments for Penicillin-Allergic Patients

  • Doxycycline 100 mg orally twice daily for 14 days is the preferred alternative for non-pregnant patients with penicillin allergy 1, 2, 3
  • Tetracycline 500 mg orally four times daily for 14 days is another alternative, though compliance is likely better with doxycycline due to less frequent dosing 1
  • Ceftriaxone 1 g daily (IM or IV) for 8-10 days may be considered as an alternative, though optimal dosing is not well established 1
  • Azithromycin is not recommended for treatment of syphilis in the United States due to documented macrolide resistance and treatment failures 1, 4

Special Considerations

HIV Co-infection

  • HIV-infected patients should receive the same penicillin regimen as HIV-negative patients 1
  • Closer follow-up is recommended for HIV-infected patients (every 3 months rather than every 6 months) 1
  • Enhanced penicillin therapy (standard benzathine penicillin with high-dose oral amoxicillin and probenecid) did not improve clinical outcomes and is not recommended 1

Penicillin Allergy Management

  • For patients whose compliance with therapy or follow-up cannot be ensured, desensitization and treatment with penicillin is recommended 1
  • Pregnant patients with penicillin allergy should be desensitized and treated with penicillin, as alternatives are not adequately studied in pregnancy 1

Follow-Up Recommendations

  • Clinical and serologic evaluation should be performed at 6 and 12 months after treatment 1
  • HIV-infected patients should be monitored more frequently (every 3 months) 1
  • Treatment failure is defined as persistent or recurring signs/symptoms, or a sustained fourfold increase in nontreponemal test titers 1
  • Failure of nontreponemal test titers to decline fourfold within 6 months may indicate treatment failure and warrants reevaluation for HIV infection 1
  • If treatment failure is suspected, CSF examination should be performed to rule out neurosyphilis 1

Treatment of Late Syphilis

  • For late latent syphilis (more than one year duration) or syphilis of unknown duration, benzathine penicillin G 2.4 million units IM weekly for 3 weeks is recommended 1
  • For neurosyphilis, aqueous crystalline penicillin G 18-24 million units daily, administered as 3-4 million units IV every 4 hours for 10-14 days is the recommended regimen 1
  • Alternative therapy for neurosyphilis is procaine penicillin 2.4 million units IM daily plus probenecid 500 mg orally four times a day, both for 10-14 days 1

Common Pitfalls and Caveats

  • Jarisch-Herxheimer reaction (fever, headache, myalgia) may occur within 24 hours after treatment, especially in early syphilis 1
  • Patients should be warned about this potential reaction but it is not an indication to avoid or discontinue therapy 1
  • Macrolide resistance in T. pallidum is widespread in the United States, making azithromycin an unsuitable alternative despite some evidence of efficacy 1, 4
  • Current benzathine penicillin G shortages may necessitate use of alternative regimens, but efforts should be made to secure penicillin when possible 5
  • Serologic tests may decline more slowly in patients who have had previous syphilis infections 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Syphilis in Non-Pregnant Individuals Allergic to Penicillin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Syphilis: antibiotic treatment and resistance.

Epidemiology and infection, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.